EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Apolipoprotein A-I Mimetics for Treatment of the Residual Risk of Cardiovascular Disease

Shin-ichiro Miura, Yasunori Suematsu, Satoshi Imaizumi, Eiji Yahiro, Takashi Kuwano, Yoshinari Uehara, Keijiro Saku

CardioMetabolic Syndrome Journal · 2021

DOI: 10.51789/cmsj.2021.1.e13 ↗

Kurz gefasst

Fachartikel in der Zeitschrift CardioMetabolic Syndrome Journal, 2021. Verfasst von Shin-ichiro Miura und 6 weiteren Autor:innen. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Ministry of Education, Culture, Sports, Science and Technology, Fukuoka University.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Förderung

  • Ministry of Education, Culture, Sports, Science and Technology
  • Fukuoka University

Zitieren

APA

Miura, S., Suematsu, Y., Imaizumi, S., Yahiro, E., Kuwano, T., Uehara, Y., & Saku, K. (2021). Apolipoprotein A-I Mimetics for Treatment of the Residual Risk of Cardiovascular Disease. CardioMetabolic Syndrome Journal. https://doi.org/10.51789/cmsj.2021.1.e13

Vancouver

Miura S, Suematsu Y, Imaizumi S, Yahiro E, Kuwano T, Uehara Y, et al. Apolipoprotein A-I Mimetics for Treatment of the Residual Risk of Cardiovascular Disease. CardioMetabolic Syndrome Journal. 2021. doi:10.51789/cmsj.2021.1.e13

BibTeX
@article{Miura2021,
  author = {Miura, Shin-ichiro and Suematsu, Yasunori and Imaizumi, Satoshi and Yahiro, Eiji and Kuwano, Takashi and Uehara, Yoshinari and Saku, Keijiro},
  title = {Apolipoprotein A-I Mimetics for Treatment of the Residual Risk of Cardiovascular Disease},
  journal = {CardioMetabolic Syndrome Journal},
  year = {2021},
  doi = {10.51789/cmsj.2021.1.e13}
}
Kostenlos starten →